首页> 外文期刊>Photodiagnosis and Photodynamic Therapy >A randomized, double-blind, placebo-controlled study of oral oxycodone plus acetaminophen for the treatment of pain in photodynamic therapy on port wine stains
【24h】

A randomized, double-blind, placebo-controlled study of oral oxycodone plus acetaminophen for the treatment of pain in photodynamic therapy on port wine stains

机译:口服羟考酮和对乙酰氨基酚治疗鲜红斑痣光动力疗法中的疼痛的随机,双盲,安慰剂对照研究

获取原文
获取原文并翻译 | 示例
       

摘要

Background: The major side-effect of photodynamic therapy (PDT) on port wine stains (PWS) is pain during the treatment. Although several strategies for controlling the pain during topical PDT achieve a reduction in the levels of pain, none were completely effective and convenient. This randomized, double-blind, placebo-controlled clinical trial was designed to evaluate the efficacy and safety of an oral analgesic for the treatment of pain in PDT on PWS. Methods: Fifty-eight patients with PWS on the face were included. The treatment and placebo groups were selected by computer randomization. The patients, doctor and statistician were blinded to the patients' groups. The analgesic contained 5 mg of oxycodone in combination with 325 mg of acetaminophen. The patient took the tablet orally 30 min before PDT. The patient was injected intravenously with 4-5 mg/kg photosensitizer PSD-007 within 5 min, and then the lesion was exposed to a 532 nm laser immediately for 30-60 min at 100mW/cm~2. The intensity of the pain during irradiation, the characteristic and beginning time of pain, and adverse effects were recorded. A visual analog scale (VAS) was used to assess the pain. Results and conclusions: The time of the pain beginning was 8.31 ±4.58 min in the treatment group and 7.10 ± 3.54 min in the placebo group, which was not significantly different (P=0.266). The VAS score in the treatment group was 7.88 ± 1.52 compared with 8.17 ± 1.12 in the placebo group, with no significant difference (P=0.422). The subgroup of age, gender, lesion location and classification between two groups had similar VAS score (P > 0.05). No serious adverse events were reported. This study found that oral oxycodone 5 mg/acetaminophen 325 mg was completely ineffective for pain relief, and age, gender, lesion location and classification did not influence the pain perception and the analgesic effect. The challenge of controlling pain during PDT on PWS remains.
机译:背景:光动力疗法(PDT)对鲜红斑痣(PWS)的主要副作用是治疗过程中的疼痛。尽管在局部PDT期间用于控制疼痛的几种策略可减轻疼痛程度,但没有一种是完全有效和方便的。这项随机,双盲,安慰剂对照的临床试验旨在评估口服镇痛药治疗PWS PDT疼痛的有效性和安全性。方法:包括58名面部PWS患者。通过计算机随机选择治疗组和安慰剂组。患者,医生和统计学家对患者分组视而不见。该止痛药含有5 mg羟考酮和325 mg对乙酰氨基酚。患者在PDT前30分钟口服了该片剂。患者在5分钟内静脉注射4-5 mg / kg光敏剂PSD-007,然后立即以100mW / cm〜2的剂量在532 nm激光下暴露30-60分钟。记录照射过程中的疼痛强度,疼痛的特征和开始时间以及不良反应。视觉模拟量表(VAS)用于评估疼痛。结果与结论:治疗组疼痛开始时间为8.31±4.58min,安慰剂组为7.10±3.54min,差异无统计学意义(P = 0.266)。治疗组的VAS评分为7.88±1.52,而安慰剂组为8.17±1.12,差异无统计学意义(P = 0.422)。两组之间的年龄,性别,病变部位和分类等亚组的VAS评分相似(P> 0.05)。没有严重不良反应的报道。这项研究发现口服羟考酮5毫克/对乙酰氨基酚325毫克对于缓解疼痛完全无效,并且年龄,性别,病变部位和分类均不影响疼痛知觉和镇痛效果。在PWS上进行PDT期间控制疼痛的挑战仍然存在。

著录项

  • 来源
    《Photodiagnosis and Photodynamic Therapy》 |2014年第2期|134-140|共7页
  • 作者单位

    Department of Laser Medicine, Chinese PLA General Hospital, Beijing 100853, China;

    Department of Laser Medicine, Chinese PLA General Hospital, Beijing 100853, China;

    Department of Laser Medicine, Chinese PLA General Hospital, Beijing 100853, China;

    Department of Laser Medicine, Chinese PLA General Hospital, Beijing 100853, China;

    Department of Laser Medicine, Chinese PLA General Hospital, Beijing 100853, China;

    Department of Laser Medicine, Chinese PLA General Hospital, Beijing 100853, China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    Pain; Photodynamic therapy; Port wine stains; Oxycodone; Acetaminophen; Clinical trial;

    机译:痛;光动力疗法;波特酒渍;羟考酮对乙酰氨基酚;临床试验;
  • 入库时间 2022-08-18 03:48:59

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号